Figures & data
Table 1 Inclusion and Exclusion Criteria
Figure 1 The comparison of one patient in the treatment group before and after treatment. (A) At admission; (B) before enrollment, no obvious necrotic tissue on the wound after debridement; (C) after the second cycle of negative-pressure wound therapy (NPWT); (D) after the fourth cycle of NPWT; (E) the application of the adhesive non-invasive skin stretching device; (F) wound healing.
![Figure 1 The comparison of one patient in the treatment group before and after treatment. (A) At admission; (B) before enrollment, no obvious necrotic tissue on the wound after debridement; (C) after the second cycle of negative-pressure wound therapy (NPWT); (D) after the fourth cycle of NPWT; (E) the application of the adhesive non-invasive skin stretching device; (F) wound healing.](/cms/asset/fc982473-9186-4600-919c-167b2ff3e83b/dmso_a_12185200_f0001_c.jpg)
Figure 2 (A–D) A comparison of one patient in the negative-pressure wound therapy (NPWT) + non-invasive skin stretching device (NSSD) group before and after treatment. (A) Before enrollment, no obvious necrotic tissue on the wound after debridement; (B) after NPWT; (C) application of the adhesive NSSD; (D) wound healing. (E–H) A comparison of one patient in the NPWT + Control group before and after treatment; (E) before enrollment, no obvious necrotic tissue on the wound after debridement; (F) during the NPWT; (G) after the NPWT; (F) wound healing.
![Figure 2 (A–D) A comparison of one patient in the negative-pressure wound therapy (NPWT) + non-invasive skin stretching device (NSSD) group before and after treatment. (A) Before enrollment, no obvious necrotic tissue on the wound after debridement; (B) after NPWT; (C) application of the adhesive NSSD; (D) wound healing. (E–H) A comparison of one patient in the NPWT + Control group before and after treatment; (E) before enrollment, no obvious necrotic tissue on the wound after debridement; (F) during the NPWT; (G) after the NPWT; (F) wound healing.](/cms/asset/c2715c1b-dd54-45a7-8c2c-d21044eae522/dmso_a_12185200_f0002_c.jpg)
Table 2 Comparison Between Treatment Groups of Patient and Wound Demographics, Comorbidities, and Medications [±s or Median (The Upper and Lower Quartiles) or Case (Composition Ratio)]